Panacea Index Logo

Command Palette

Search for a command to run...

The effects of spinach-derived thylakoid supplementation in combination with calorie restriction on anthropometric parameters and metabolic profiles in obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial.

Nutrition journal
January 1, 1970
Fatemeh Pourteymour Fard Tabrizi et al. (4 authors)
Journal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to evaluate the effects of spinach-derived thylakoids combined with a calorie-restricted diet on anthropometric and metabolic profiles in obese women with PCOS.

Results Summary

The thylakoid group showed significant improvements in weight, waist circumference, fat mass, insulin levels, and insulin resistance markers compared to the placebo group. No significant differences were observed in other metabolic or hormonal parameters.

Population

Obese women with polycystic ovary syndrome (PCOS).

Effective Dosage

5 g/day thylakoid.

Duration

12 weeks.

Interactions

None mentioned.

Extracted Claims (7)
InterventionDirectionEndpointPopulationDosageImpactClaim #
spinach-derived thylakoids supplementation combined with a calorie-restricted diet
decrease
weight
obese women with the polycystic ovary syndrome (PCOS)
-6.97 ± 0.52 kg vs. -3.19 ± 0.72 kg
significant decreases
#1
spinach-derived thylakoids supplementation combined with a calorie-restricted diet
decrease
waist circumference
obese women with the polycystic ovary syndrome (PCOS)
-7.78 ± 2.50 cm vs. -3.73 ± 1.40 cm
significant decreases
#2
spinach-derived thylakoids supplementation combined with a calorie-restricted diet
decrease
fat mass
obese women with the polycystic ovary syndrome (PCOS)
-5.19 ± 0.53 kg vs. -1.36 ± 0.39 kg
significant decreases
#3
spinach-derived thylakoids supplementation combined with a calorie-restricted diet
decrease
insulin levels
obese women with the polycystic ovary syndrome (PCOS)
-5.40 ± 1.86 vs. -1.19 ± 0.85 μU/mL
significant decreases
#4
spinach-derived thylakoids supplementation combined with a calorie-restricted diet
decrease
insulin resistance markers
obese women with the polycystic ovary syndrome (PCOS)
-
decreased significantly
#5
spinach-derived thylakoids supplementation combined with a calorie-restricted diet
decrease
serum levels of testosterone
obese women with the polycystic ovary syndrome (PCOS)
-
decreased significantly
#6
spinach-derived thylakoids supplementation combined with a calorie-restricted diet
no change
other parameters
obese women with the polycystic ovary syndrome (PCOS)
-
did not show significant differences
#7
Abstract

BACKGROUND: There is a promising outlook regarding the potential effect of spinach-derived thylakoids in the management of obesity and its associated metabolic disturbances. This research aimed to evaluate the effects of spinach-derived thylakoids supplementation combined with a calorie-restricted diet on anthropometric and metabolic profiles in obese women with the polycystic ovary syndrome (PCOS). METHODS: In a 12-week double-blind placebo-controlled randomized clinical trial, 48 females with obesity and PCOS were randomly allocated into either intervention (5 g/day thylakoid) or placebo (5 g/day cornstarch) groups along with calorie-restricted diets. Anthropometric measures, physical activity levels, dietary intakes, insulin resistance markers, as well as serum levels of insulin, fasting blood glucose (FBG), non-esterified fatty acids (NEFA), and sex hormones including dehydroepiandrosterone sulfate (DHEAS), follicle-stimulating hormone (FSH), luteinizing hormone (LH), sex hormone-binding globulin (SHBG), and free androgen index (FAI) were evaluated pre-and post-intervention. RESULTS: After the 12-week intervention, there were significant decreases in weight (- 6.97 ± 0.52 vs. -3.19 ± 0.72 kg; P < 0.001), waist circumference (- 7.78 ± 2.50 vs. -3.73 ± 1.40 cm; P < 0.001), fat mass (- 5.19 ± 0.53 vs. -1.36 ± 0.39 kg; P < 0.001), and insulin levels (- 5.40 ± 1.86 vs. -1.19 ± 0.85 μU/mL; P < 0.001) in the spinach-derived thylakoid group compared to the placebo group. Furthermore, insulin resistance markers and serum levels of testosterone decreased significantly in the thylakoid group compared to the placebo group (P < 0.05). The changes in other parameters did not show significant differences between the two groups. CONCLUSIONS: Spinach-derived thylakoid supplementation resulted in more favorable improvements in anthropometric indices and insulin sensitivity compared to the calorie restriction alone. TRIAL REGISTRATION: The study was approved by the Ethics Committee of Research Vice-chancellor of Tabriz University of Medical Sciences, Tabriz, Iran, and was registered in the Iranian Registry of Clinical Trials (registration ID: IRCT20140907019082N9 ).

Medical Subject Headings (MeSH)
Blood GlucoseCaloric RestrictionDietary SupplementsDouble-Blind MethodFemaleHumansInsulinInsulin ResistanceIranMetabolomeObesityPolycystic Ovary SyndromeSpinacia oleraceaTestosteroneThylakoids
Study Links
Quality Scores
SafetyNot Assessed
Efficacy85/10
Quality80/10
Citation Metrics
Total Citations15
Citations/Year3.0
Relative Citation Ratio0.72
NIH Percentile38.6%
Research Impact Scores
APT Score0.75
Weight Score1.70
Normalized Score0.70
Related Supplements
The effects of spinach-derived thylakoid supplementation in ... | Panacea Index